Annual Shareholders Equity
$288.39 M
-$141.67 M-32.94%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual stockholders equity is currently $288.39 million, with the most recent change of -$141.67 million (-32.94%) on 31 December 2023. During the last 3 years, it has risen by +$292.79 million (+6655.13%). NAMS annual shareholders equity is now -32.94% below its all-time high of $430.07 million, reached on 31 December 2022.NAMS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$378.86 M
-$8.58 M-2.21%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly stockholders equity is currently $378.86 million, with the most recent change of -$8.58 million (-2.21%) on 30 September 2024. NAMS quarterly shareholders equity is now -17.44% below its all-time high of $458.89 million, reached on 30 June 2023.NAMS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.9% | - |
| 3 y3 years | +6655.1% | - |
| 5 y5 years | - | - |
NAMS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.9% | +6655.1% | -17.4% | +572.0% |
| 5 y | 5 years | -32.9% | +6655.1% | -17.4% | +572.0% |
| alltime | all time | -32.9% | +6655.1% | -17.4% | +572.0% |
NewAmsterdam Pharma Company NV Ordinary Shares Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $378.86 M(-2.2%) |
| June 2024 | - | $387.44 M(-5.9%) |
| Mar 2024 | - | $411.80 M(+42.8%) |
| Dec 2023 | $288.39 M | $288.39 M(-37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $458.89 M(+6.7%) |
| Dec 2022 | $430.07 M(+662.9%) | $430.07 M(+123.2%) |
| June 2022 | - | $192.65 M(+241.7%) |
| Dec 2021 | $56.37 M(-1381.4%) | $56.37 M |
| Dec 2020 | -$4.40 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual stockholders equity?
- What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual shareholders equity year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV Ordinary Shares?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual stockholders equity?
The current annual shareholders equity of NAMS is $288.39 M
What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual stockholders equity is $430.07 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual shareholders equity year-on-year change?
Over the past year, NAMS annual stockholders equity has changed by -$141.67 M (-32.94%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly stockholders equity?
The current quarterly shareholders equity of NAMS is $378.86 M
What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly stockholders equity is $458.89 M